Praxis Precision Medicines, Inc.
Public
PRX
SectorHealthcare
CountryUnited States
Market cap9.45B
Praxis Precision Medicines, Inc.,A clinical-stage biopharmaceutical company translating genetic insights into breakthrough therapies for central nervous system disorders.
